New technological frontier against gastric cancer in the Isla

Gastroenterologists of the Netherlands initiate the practice of submucosal endoscopy detecting premalignant lesions

Dr. Carlos Micames, Past President of the Puerto Rican Gastroenterology Association and Dr. Joel de Jesús, Gastroenterologist

Belinda Z. Burgos González
Agencia Latina de Noticias Medicina y Salud Pública

In Puerto Rico a state-of-the-art technology is practiced that allows lesions to be removed altogether due to a single intervention and that, in comparison with a surgeon, frees the patient from having a debilitating diagnosis and a gastric cancer.

And that submucosal endoscopy or endoscopic submucosal dissection (DSE) is an endoscopic therapeutic technique that can detect digestive neoplasias in many stages and develop with the final decision of a curative radical dissection with a complete dissection.

In an exclusive interview with Medicina y Salud Pública (MSP), gastroenterologists, doctors Carlos Micames, former president of the Puerto Rican Association of Gastroenterology and Joel de Jesús, with private practice of one more decade in the municipality of Guayama, announcement of the technique in patients that meet the clinical criteria.

An endoscopy is a procedure that allows the physician to remove the interior of his body to help diagnose and treat the esophagus’ symptoms and affections, the stomach and the superior part of the intestine or duodenum.

Ambos gastroenterologists are the only ones in the island to employ the DSE, aseguraron.

“Removal lesions traversed by an endoscopy are the superior part of the superior digestive tract or colonoscopy and are a lesion in the colon or rectum. The difference of this technique in comparison with others to remove this type of lesions, as for example the polypectomy or mucosal resection, has a limit on the size of the lesion that we can remove. Casi is always limited to a tumor or lesion that is no more than 2 centimeters long ”, explained in the first instance.

“When different we make a mucosal resection, we do not have the limit and we remove one solo block. And this is the big difference between these endoscopic techniques and the others. “As he opened the door, he had to deal with lesions that quizzes were taking place in our hospital and he allowed these patients to benefit from an endoscopic resection without having to undergo surgery,” he said.

Although the technique represents a significant advance for the campus of gastroenterology, there is a risk of complications that include hemorrhage or perforation, which are obligatory for these specialists who have advanced endoscopy training, both of which are ambient.

“It’s important since the detection of tantrums in malignant lesions such as premalignancies,” assured Dr. Micames.

Clinical scenario of gastrointestinal affections

On the other hand, specialists specialize in that cancer, esophageal and colon colon cancer affects the Hispanic population due to dietary practices and the incidence of genetics.

“Puerto Rico, like many other countries, has a significant incidence of cancer, as it is a corrective cancer that has deviated from its dietary and genetic practices. Without embarrassment, we are increasing in cases of esophageal cancer and gastric cancer. In particular, esophageal cancer has been reported in North America, the Caribbean and Suramérica and one of the theories is the increase in obesity ”, scored by Dr. Micames, with practice at the Bella Vista Hospital in Mayagüez.

“If we have more adenocarcinoma-type cancers (type of cancer that begins in the cells) debit to the obesity and gastroesophageal reflux disease is the most common. For its part, the gastric cancer is what it detects by its part because it is more powerful because its lesions are very small ”, assured.

Both specialists indicate that between the clinical criteria for submucosal endoscopy are indicated in premalignant lesions and malignancies between 2 and 3 centimeters. Precisely by this indication the medicines refer to the importance of the referendum at the time of these patients by their primary medicines.